INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹87 Cr | ₹73 Cr | ₹60 Cr | ₹47 Cr | ₹38 Cr |
What is the latest Total Current Assets ratio of INDO US BIOTECH ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹38 Cr |
How is Total Current Assets of INDO US BIOTECH Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 18.66 | |
| Mar2024 | ₹73 Cr | 22.00 | |
| Mar2023 | ₹60 Cr | 27.31 | |
| Mar2022 | ₹47 Cr | 23.40 | |
| Mar2021 | ₹38 Cr | - | |
Compare Total Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹199.3 Cr | -3.1% | -24.8% | -46.6% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,634.6 Cr | -0.8% | -17.7% | -12.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,168.6 Cr | 5.6% | -9.3% | -24.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,709.7 Cr | -4.1% | -15.9% | -24.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹861.0 Cr | -1.6% | -10.7% | -38.2% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹336.5 Cr | 2.6% | -18.9% | -36.2% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -3.1% |
-24.8% |
-46.6% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses